ArticleLipids in health and disease2016

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy.

Charles J Glueck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.